Search research articles
Contact Us
Filters
Showing results (61-70 of 63) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 63 results.
Plos One
|
March 8, 2013
The novel Mas agonist, CGEN-856S, attenuates isoproterenol-induced cardiac remodeling and myocardial infarction injury in rats
Sílvia Q Savergnini, Danielle Ianzer, Mariana B L Carvalho, et al.
Hypertension (Dallas, Tex. : 1979)
|
May 19, 2010
Vascular relaxation, antihypertensive effect, and cardioprotection of a novel peptide agonist of the MAS receptor
Silvia Quintão Savergnini, Merav Beiman, Roberto Queiroga Lautner, et al.
Blood Cells, Molecules & Diseases
|
October 7, 2009
Force majeure: therapeutic measures in response to restricted supply of imiglucerase (Cerezyme) for patients with Gaucher disease
Carla E M Hollak, Stephan vom Dahl, Johannes M F G Aerts, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 63) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 63 results.
Plos One
|
March 8, 2013
The novel Mas agonist, CGEN-856S, attenuates isoproterenol-induced cardiac remodeling and myocardial infarction injury in rats
Sílvia Q Savergnini, Danielle Ianzer, Mariana B L Carvalho, et al.
Hypertension (Dallas, Tex. : 1979)
|
May 19, 2010
Vascular relaxation, antihypertensive effect, and cardioprotection of a novel peptide agonist of the MAS receptor
Silvia Quintão Savergnini, Merav Beiman, Roberto Queiroga Lautner, et al.
Blood Cells, Molecules & Diseases
|
October 7, 2009
Force majeure: therapeutic measures in response to restricted supply of imiglucerase (Cerezyme) for patients with Gaucher disease
Carla E M Hollak, Stephan vom Dahl, Johannes M F G Aerts, et al.
Page
of 7